tiprankstipranks
Trending News
More News >
Coeptis Therapeutics Holdings Inc. (COEP)
:COEP
US Market
Advertisement

Coeptis Therapeutics Holdings (COEP) Price & Analysis

Compare
136 Followers

COEP Stock Chart & Stats


Coeptis Therapeutics Holdings News

COEP FAQ

What was Coeptis Therapeutics Holdings Inc.’s price range in the past 12 months?
Coeptis Therapeutics Holdings Inc. lowest stock price was $2.31 and its highest was $13.70 in the past 12 months.
    What is Coeptis Therapeutics Holdings Inc.’s market cap?
    Coeptis Therapeutics Holdings Inc.’s market cap is $38.95M.
      When is Coeptis Therapeutics Holdings Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Coeptis Therapeutics Holdings Inc.’s earnings last quarter?
      Currently, no data Available
      Is Coeptis Therapeutics Holdings Inc. overvalued?
      According to Wall Street analysts Coeptis Therapeutics Holdings Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Coeptis Therapeutics Holdings Inc. pay dividends?
        Coeptis Therapeutics Holdings Inc. does not currently pay dividends.
        What is Coeptis Therapeutics Holdings Inc.’s EPS estimate?
        Coeptis Therapeutics Holdings Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Coeptis Therapeutics Holdings Inc. have?
        Coeptis Therapeutics Holdings Inc. has 3,513,838 shares outstanding.
          What happened to Coeptis Therapeutics Holdings Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Coeptis Therapeutics Holdings Inc.?
          Currently, no hedge funds are holding shares in COEP

          Coeptis Therapeutics Holdings Stock Smart Score

          3
          Underperform
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Positive
          20 days / 200 days
          Momentum
          158.15%
          12-Months-Change

          Fundamentals

          Return on Equity
          -197.22%
          Trailing 12-Months
          Asset Growth
          45.87%
          Trailing 12-Months

          Company Description

          Coeptis Therapeutics Holdings Inc.

          Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.

          Coeptis Therapeutics Holdings (COEP) Earnings & Revenues

          Currently, no data available
          Please return soon. This page is being updated.
          Similar Stocks
          Company
          Price & Change
          Follow
          Akari Therapeutics
          X4 Pharmaceuticals
          NRX Pharmaceuticals
          LAVA Therapeutics
          Cadrenal Therapeutics, Inc.

          Ownership Overview

          3.03%3.11%96.74%
          3.03%
          Insiders
          ― Other Institutional Investors
          96.74% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis